Market Access

Work for an international innovation company headquartered in Moscow, with 11 factories in Russia and Europe, as well as branches in the USA, Germany, Turkey, Saudi Arabia, and the UAE.

R-Pharm Holding generates over $2 billion in revenue and employs more than 5,000 staff.

Lead the launch-360, a unique original drug, Olokizumab (IL-6), for the treatment of rheumatoid arthritis.

Olokizumab is the first interleukin-6 (IL-6) inhibitor approved for treatment of rheumatoid arthritis which blocks directly cytokine instead of its receptor.

Efficacy and safety of Olokizuamb has been demonstrated in the large-scale international programme of Phase III clinical trials that was carried out in 19 countries worldwide and involved 2,440 patients, including patients from the USA, European countries. The results obtained in international clinical trial programme have been published in the leading peer-reviewed journals worldwide: Annals of the Rheumatic Diseases, Modern Rheumatology and The New England Journal of Medicine.

Responsibilities

Compete with pharmaceutical giants, leveraging marketing and extension resources without becoming bogged down in endless approvals, while genuinely providing Vietnamese patients with innovative drugs.

Take full responsibility for the A&P budget and serve as the key marketing expert in Vietnam across the company. Manage marketing initiatives.

This role offers the opportunity to demonstrate your skills not in a narrow area, but as a true owner of the product, influencing all aspects of its life cycle.

In the medium term, anticipate growth in the registered portfolio in Vietnam and neighboring countries, which can offer incredible career prospects.

Qualifications

Bachelor's degree in science or equivalent experience

3+ years experience in marketing (big-pharma)

Successful experience of launching hospital drugs

Ability to multi-task

Strong verbal, written, and organizational skills

Location: Vietnam